Tech Company Financing Transactions
Element Biosciences Funding Round
Element Biosciences, based in San Diego, secured $276 million from Fidelity Management & Research Company, Foresite Capital and Janus Henderson Investors.
Transaction Overview
Company Name
Announced On
7/1/2021
Transaction Type
Venture Equity
Amount
$276,000,000
Round
Series C
Investors
Proceeds Purpose
Proceeds from the Series C financing will be used to scale the commercial organization in anticipation of, as well as fund, the launch of the company's next-generation sequencing solution.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
9880 Campus Point Dr. 210
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
At Element, we innovate through a combination of cutting-edge technologies and established solutions. Our practices govern through a passion and fervor for rigorous science, such that data and results drive timely decisions in ever evolving markets. We take risks to challenge the status quo. We celebrate success and thrive in failures.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
John Stuelpnagel
Chief Executive Officer
Molly He
Chief Technical Officer
Michael Previte
Vice President
Steve Potter
VP - Bus. Development
Jeffrey Journey
VP - Engineering
Francisco Garcia
VP - Finance
Logan Zinser
VP - General Counsel
David Melaugh
VP - Operations
Jeffrey Labbadia
Browse more venture capital transactions:
Prev: 7/1/2021: DataRobot venture capital transaction
Next: 7/1/2021: Sevco Security venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs